Prostate cancer is the second leading cause of cancer re-lated deaths among men. Because of the slow growing na-ture of prostate cancer, sometimes surgical treatment is not required for less aggressive cancers. Recent debates over prostate-specific antigen (PSA) screening have drawn new attention to prostate cancer. Genome-based screening can potentially help in assessing the risk of developing prostate cancer. Due to the complicated nature of prostate cancer, studying the entire genome is essential to find genomic traits. Due to the high cost of studying all Single Nucleotide Poly-morphisms (SNPs), it is essential to find tag SNPs which can represent other SNPs. Earlier methods to find tag SNPs using associations between SNPs either use SN...
A recent genome-wide association study found that genetic variants on chromosomes 3, 6, 7, 10, 11, 1...
Genome-wide association studies have identified multiple genetic variants associated with prostate c...
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To i...
BackgroundNo single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have bee...
BACKGROUND: No single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have b...
BACKGROUND: No single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have ...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
BACKGROUND: Although case-control studies have identified numerous single nucleotide polymorphisms (...
Numerous Genome Wide Association (GWA) studies of large populations have provided limited biomarkers...
Free to read on publisher website A recent genome-wide association study found that genetic variants...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
A recent genome-wide association study found that genetic variants on chromosomes 3, 6, 7, 10, 11, 1...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
A recent genome-wide association study found that genetic variants on chromosomes 3, 6, 7, 10, 11, 1...
Genome-wide association studies have identified multiple genetic variants associated with prostate c...
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To i...
BackgroundNo single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have bee...
BACKGROUND: No single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have b...
BACKGROUND: No single-nucleotide polymorphisms (SNPs) specific for aggressive prostate cancer have ...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNP...
BACKGROUND: Although case-control studies have identified numerous single nucleotide polymorphisms (...
Numerous Genome Wide Association (GWA) studies of large populations have provided limited biomarkers...
Free to read on publisher website A recent genome-wide association study found that genetic variants...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
A recent genome-wide association study found that genetic variants on chromosomes 3, 6, 7, 10, 11, 1...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
A recent genome-wide association study found that genetic variants on chromosomes 3, 6, 7, 10, 11, 1...
Genome-wide association studies have identified multiple genetic variants associated with prostate c...
Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To i...